BBC News |
‘Monumental U-turn’ on cancer drug
BBC News A pioneering and life-extending drug repeatedly deemed too expensive will now be offered on the NHS in England. It is the result of a confidential deal between the health service and the drug company Roche. Kadcyla, the undiscounted cost of which had … Possible Role for Immunotherapy in Early-Stage Breast Cancer Overcoming Drug Resistance in the Treatment of Metastatic Breast Cancer NICE, Roche Reach Deal on Breast Cancer Drug |
View original article
Author:
Powered by WPeMatico